Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Core Scientific (CORZ) Accumulated Expenses (2020 - 2025)

Historic Accumulated Expenses for Core Scientific (CORZ) over the last 6 years, with Q3 2025 value amounting to $358.3 million.

  • Core Scientific's Accumulated Expenses rose 102926.31% to $358.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $358.3 million, marking a year-over-year increase of 102926.31%. This contributed to the annual value of $64.7 million for FY2024, which is 6399.94% down from last year.
  • Core Scientific's Accumulated Expenses amounted to $358.3 million in Q3 2025, which was up 102926.31% from $180.6 million recorded in Q2 2025.
  • Core Scientific's Accumulated Expenses' 5-year high stood at $358.3 million during Q3 2025, with a 5-year trough of $692220.0 in Q1 2021.
  • In the last 5 years, Core Scientific's Accumulated Expenses had a median value of $64.7 million in 2024 and averaged $81.2 million.
  • As far as peak fluctuations go, Core Scientific's Accumulated Expenses skyrocketed by 1696540000.0% in 2021, and later crashed by 7354.63% in 2022.
  • Core Scientific's Accumulated Expenses (Quarter) stood at $67.9 million in 2021, then tumbled by 73.55% to $18.0 million in 2022, then soared by 900.65% to $179.6 million in 2023, then crashed by 64.0% to $64.7 million in 2024, then soared by 454.0% to $358.3 million in 2025.
  • Its Accumulated Expenses was $358.3 million in Q3 2025, compared to $180.6 million in Q2 2025 and $95.5 million in Q1 2025.